Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of randomized controlled trials

Autor: Patoulias, Dimitrios, Stavropoulos, Konstantinos, Imprialos, Konstantinos, Katsimardou, Alexandra, Kalogirou, Maria-Styliani, Koutsampasopoulos, Konstantinos, Zografou, Ioanna, Papadopoulos, Christodoulos, Karagiannis, Asterios, Doumas, Michael
Zdroj: In Diabetes Research and Clinical Practice December 2019 158
Databáze: ScienceDirect